Joint Formulary & PAD

Co-amilofruse (Amiloride hydrochloride/frusemide) - Oedema

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Green
Formulations :
  • Tablets
Associated Icons :
Restrictions / Comments :

Documentation

  • No records returned.

PAD Profile

ChemicalSubstance :
Co-amilofruse (Amiloride hydrochloride/frusemide)
Indication :
Oedema
Group Name :
Keywords :
potassium sparing diuretics
Brand Names Include :
Frumil, Frumil LS
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
0

Other Indications

Below are listed other indications that Co-amilofruse (Amiloride hydrochloride/frusemide) is used to treat.

  • No records returned.

Committee Recommendations (2)

GENERIC Co-Amilofruse has been considered by the PCN and has been assigned a GREEN traffic light status.

NOTE - the branded product, Frumil, was considered BLACK at the PCN in May 2017.
This drug has been agreed as appropriate for initiation in Primary Care and/or continued in Primary Care following a recommendation from specialists in other health care sectors. Following consideration by the PCN, it has been assigned a GREEN traffic light status.